Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | VDR | P11473 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | GALR3 | O60755 | 1/20 | 0.33 |
| ▸ | PGD | P52209 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21905690 | 0.80 | TSHR (0.46) | TSHRVDRPKM | |
| SCHEMBL29854834 | 0.77 | PKM (0.60) | TSHRKDM4ETP53PKMLMNA | |
| SCHEMBL17778025 | 0.77 | PKM (0.60) | TSHRKDM4ETP53PKMLMNA | |
| SCHEMBL11922792 | 0.77 | PKM (0.48) | TSHRVDRPKM | |
| SCHEMBL6566706 | 0.75 | PKM (0.41) | TSHRVDRPKM | |
| SCHEMBL24475270 | 0.73 | TSHR (0.39) | TSHRVDRPKM | |
| SCHEMBL27414986 | 0.73 | TSHR (0.39) | TSHRVDRPKM | |
| SCHEMBL12967296 | 0.72 | — | — | |
| SCHEMBL20331107 | 0.72 | TP53 (0.39) | KDM4ETP53 | |
| SCHEMBL15510196 | 0.71 | KDM4E (0.67) | TSHRKDM4ETP53LMNAHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200140463-A1 | METAL ALKOXIDE COMPOUND, THIN FILM FORMING RAW MATERIAL, AND THIN FILM PRODUCTION METHOD | ADEKA CORPORATION (JP) | 2020-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200140463-A1 | METAL ALKOXIDE COMPOUND, THIN FILM FORMING RAW MATERIAL, AND THIN FILM PRODUCTION METHOD | TMEM109, AGPAT5, ALKBH5 | TSHR 4504/4885KDM4E 964/4885VDR 4881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.